CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,390 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01071278
NCT01071278N/ACompleted

Lipid Management in Clinical Practice

Merck Sharp & Dohme LLC·observational·Posted Feb 19, 2010·Updated Aug 11, 2015

In Brief

An observational study for Lipid Metabolism Disorder. Completed, enrolled 2,390 participants.

Detailed Summary

The aim of this observational program is to generate data on the use of Tredaptive (nicotinic acid/laropiprant) for lipid management under routine medical practice conditions.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 19, 2010
Enrollment StartOct 1, 2009
Primary CompletionFeb 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 16.4 years ago